| Product Code: ETC12954415 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multiplexed Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multiplexed Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multiplexed Diagnostics Market - Industry Life Cycle |
3.4 Israel Multiplexed Diagnostics Market - Porter's Five Forces |
3.5 Israel Multiplexed Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Multiplexed Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Multiplexed Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Israel Multiplexed Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Israel Multiplexed Diagnostics Market Revenues & Volume Share, By Detection Method, 2021 & 2031F |
4 Israel Multiplexed Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel |
4.2.2 Growing adoption of personalized medicine and targeted therapies |
4.2.3 Technological advancements in multiplexed diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic tests in Israel |
4.3.2 Limited reimbursement policies for multiplexed diagnostics |
4.3.3 High initial investment and operational costs for setting up multiplexed diagnostic facilities |
5 Israel Multiplexed Diagnostics Market Trends |
6 Israel Multiplexed Diagnostics Market, By Types |
6.1 Israel Multiplexed Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Multiplexed Diagnostics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Multiplexed Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Israel Multiplexed Diagnostics Market Revenues & Volume, By Microarray-Based, 2021 - 2031F |
6.1.5 Israel Multiplexed Diagnostics Market Revenues & Volume, By Bead-Based, 2021 - 2031F |
6.1.6 Israel Multiplexed Diagnostics Market Revenues & Volume, By Cell-Based, 2021 - 2031F |
6.1.7 Israel Multiplexed Diagnostics Market Revenues & Volume, By Point-of-Care, 2021 - 2031F |
6.2 Israel Multiplexed Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Multiplexed Diagnostics Market Revenues & Volume, By Infectious Disease, 2021 - 2031F |
6.2.3 Israel Multiplexed Diagnostics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.4 Israel Multiplexed Diagnostics Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.5 Israel Multiplexed Diagnostics Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.6 Israel Multiplexed Diagnostics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.3 Israel Multiplexed Diagnostics Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Israel Multiplexed Diagnostics Market Revenues & Volume, By Digital PCR, 2021 - 2031F |
6.3.3 Israel Multiplexed Diagnostics Market Revenues & Volume, By Microfluidics, 2021 - 2031F |
6.3.4 Israel Multiplexed Diagnostics Market Revenues & Volume, By Immunoassays, 2021 - 2031F |
6.3.5 Israel Multiplexed Diagnostics Market Revenues & Volume, By NGS, 2021 - 2031F |
6.3.6 Israel Multiplexed Diagnostics Market Revenues & Volume, By Biosensors, 2021 - 2031F |
6.4 Israel Multiplexed Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Multiplexed Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Israel Multiplexed Diagnostics Market Revenues & Volume, By Plasma, 2021 - 2031F |
6.4.4 Israel Multiplexed Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.5 Israel Multiplexed Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
6.4.6 Israel Multiplexed Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.5 Israel Multiplexed Diagnostics Market, By Detection Method |
6.5.1 Overview and Analysis |
6.5.2 Israel Multiplexed Diagnostics Market Revenues & Volume, By Fluorescence, 2021 - 2031F |
6.5.3 Israel Multiplexed Diagnostics Market Revenues & Volume, By Luminescence, 2021 - 2031F |
6.5.4 Israel Multiplexed Diagnostics Market Revenues & Volume, By Chemiluminescence, 2021 - 2031F |
6.5.5 Israel Multiplexed Diagnostics Market Revenues & Volume, By Colorimetric, 2021 - 2031F |
6.5.6 Israel Multiplexed Diagnostics Market Revenues & Volume, By Multiplex PCR, 2021 - 2031F |
7 Israel Multiplexed Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Multiplexed Diagnostics Market Export to Major Countries |
7.2 Israel Multiplexed Diagnostics Market Imports from Major Countries |
8 Israel Multiplexed Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of multiplexed diagnostics in healthcare facilities |
8.2 Number of research collaborations and partnerships for developing new multiplexed diagnostic tests |
8.3 Rate of integration of multiplexed diagnostics in treatment decision-making processes |
9 Israel Multiplexed Diagnostics Market - Opportunity Assessment |
9.1 Israel Multiplexed Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Multiplexed Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Multiplexed Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Israel Multiplexed Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Israel Multiplexed Diagnostics Market Opportunity Assessment, By Detection Method, 2021 & 2031F |
10 Israel Multiplexed Diagnostics Market - Competitive Landscape |
10.1 Israel Multiplexed Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Multiplexed Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here